Cheap Antidepressant Shows Promise , for Treating Early COVID <br />in High-Risk Adults.<br />Fluvoxamine <br />is a pill that is used <br />to treat depression and <br />obsessive compulsive disorder.<br />It also has <br />anti-inflammatory properties.<br />According to researchers from <br />McMaster University in Hamilton, Ontario.<br />the pill reduced the need for <br />hospitalization in high-risk adults <br />who contracted COVID-19.<br />The researchers conducted a study on widely-used medications that may be used to treat COVID-19.<br />The study involved 1,500 Brazilians at risk <br />of severe COVID-19 who took either <br />fluvoxamine or a placebo for 10 days.<br />Five percent fewer participants who took fluvoxamine were hospitalized than those who took the placebo.<br />The results of the study have been shared with the World Health Organization (WHO).<br />If WHO recommends this, you will see it widely taken up. , Dr. Edward Mills, McMaster University, <br />Yahoo News.<br />We hope it will lead to a lot of lives saved, Dr. Edward Mills, McMaster University, <br />Yahoo News.<br />Using fluvoxamine as a course of treatment <br />for COVID-19 costs $4.<br />as compared to the experimental pill <br />developed by Merck, which costs $700...<br />and the antibody IV treatment, <br />which costs $2,000 per treatment course.<br />Questions remain about the best dosing of <br />the pill and whether or not it would <br />be effective for those at low risk of severe disease
